Hot Life Science Investor Mandate 4: VC Arm of Merchant Bank Seeks Pain, Neuromodulation and Orthopedic Technologies

1 Oct

The venture arm of a New Jersey-based merchant bank looks at life science companies that have or are close to acquiring FDA approval, and are now seeking commercial capital. The firm typically leads and co-invests, and will look at early stage companies if the management team is well versed in the specific life science space. The firm typically invests between $5 million and $10 million, and opportunistically invests based on transaction. The firm typically makes 2-3 deals per year, and has invested over $40 million in the past year. The firm currently holds over $60 million in capital. The firm focuses on the east coast of USA, specifically from Boston to Florida, but is also open to Eastern Canada, including Toronto and Montreal.

The firm makes 60% of their activity in medtech devices, including those in healthcare IT and diagnostics. Around 20% of the firm’s activity involves biotech pharmaceuticals and therapeutics. The firm is interested in PMA and 510K medical devices, as well as software-enabled devices and lab equipment and drug development enabling technologies. The firm is open to all diagnostic subsectors—genomics, imaging, and in-vitro—as well as all therapeutic subsectors, though are focused on small molecules. The firm is interested in Phase III to on the market therapeutics, and is interested in medical devices in the development stage that have passed the preliminary design phase with a prototype. The firm has historically invested in assays in cancer diagnostics, as well as devices in the cardiovascular space. The firm is now focusing on opportunities in the pain and neuromodulation space, as well as orthopedics, cancer, and pediatric neurology.

The firm prefers a strong management team that has significant foothold in the space, and has great potential to make good partners. The firm will help fill the management team if necessary, and typically takes a board seat after an investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: